Navigation Links
Bionovo Announces 2009 Highlights and Year-End Financial Results
Date:3/15/2010

ties relating to product development, efficacy and safety, regulatory actions or delays, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, physician acceptance, third party reimbursement, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Bionovo, Inc. is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

Financial Tables on Following Pages

    
    
                                    Bionovo, Inc.
                           (A Development Stage Company) 
                        Consolidated Statements of Operations
                                    (Unaudited)
    
                                                                   Accumulated
                                                                      from
                                                                    February
                                                                    1, 2002
                                                                   (Date of
                                                      
'/>"/>
SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Bionovo, Inc. to Announce Fourth Quarter and Fiscal Year 2009 Financial Results on Monday, March 15, 2010
2. Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
3. Bionovo Announces Third Quarter 2009 Highlights and Financial Results
4. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2009 Financial Results on Thursday, November 5, 2009
5. Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
6. Bionovo Announces Second Quarter 2009 Highlights and Financial Results
7. Bionovos Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity
8. Bionovo Announces First Quarter 2009 Highlights and Financial Results
9. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
11. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... IRVINE, Calif. , Nov. 20, 2014  Edwards ... leader in the science of heart valves and hemodynamic ... corporate giving in 2014 to support a strong launch ... Heartbeat Matters , and to improve the global communities ... In 2014, Edwards, global corporate giving will exceed $8 ...
(Date:11/21/2014)... , Nov. 20, 2014  RedRick Technologies, a ... and reading room environment guidance, has helped the ... radiology reading room, which may also serve as ... Penn Medicine. "In line with ... College of Radiology,s Imaging 3.0 ™ initiative, ...
(Date:11/21/2014)... Michael DeMarco (42) erinnert sich ... Februar 2014 zugetragen hat. Seine Tochter Aly Demarco (13) ... Video - http://youtu.be/5cVoMCe0uiE „Man ... Training zu machen", erzählt Michael DeMarco . „Meine ... begeisterte Anhänger der CrossFit-Trainingsmethode. Ich war auf dem Fahrrad, ...
Breaking Medicine Technology:Edwards Lifesciences Increases Charitable Giving In 2014 To Support Launch Of Every Heartbeat Matters 2RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 2RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 3Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3
... /PRNewswire-FirstCall/ --,Wyeth Pharmaceuticals, a division of Wyeth ... clinical study,results on bifeprunox at an international ... an investigational,treatment for adult patients diagnosed with ... lipid profile, similar to,placebo. In addition, increases ...
... 30, 2007 /PRNewswire-FirstCall/ - Helix today,announced positive results ... Interferon Alpha-2b in women with human papilloma virus,(HPV) ... a clinically efficacious response to treatment,in nearly half ... an excellent safety profile, with no significant local,intolerance ...
Cached Medicine Technology:Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 2Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 3Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 4Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 5Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 6Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 2Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 3Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 4Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 5Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 6
(Date:11/22/2014)... 2014 Discount-Dress.com is an important ... firm is to increase the company’s online market share by ... selection of bridesmaid dresses and announced a bridesmaid dress promotion ... until Dec. 30, 2014. All the dresses from this company ... , In fact, Discount-Dress.com is very good at manufacturing wedding ...
(Date:11/22/2014)... PA (PRWEB) November 22, 2014 "My ... the pain caused by the machine," said an inventor ... she had to go back a second time because ... invention idea." , She developed the patent-pending MAMO EASY ... breast cancer. The design saves the patient from the ...
(Date:11/22/2014)... 2014 (HealthDay News) -- The wide variety and complexity ... threat for people with food allergies, an expert warns. ... many types of food allergies that it can be ... Dr. Guha Krishnaswamy, director of allergy and clinical immunology ... hospital news release. "If you know you have ...
(Date:11/22/2014)... This month has been a historical time for Angeldress.co.uk, an ... reviews from some renowned review websites. Recently, the company has ... new selection of wonderful sexy wedding dresses to its website. ... and up to an 80% discount on any order over ... most suitable dress at Angeldress.co.uk, which has garnered a hard ...
(Date:11/22/2014)... Petersburg, FL (PRWEB) November 22, 2014 ... Kitchen Innovations are pleased to announce that Ashley ... the Thanksgiving #PayItForward contest. , Ms. Lombardo entered ... from Kitchen Innovations. She wrote of how her friend ... young daughters as a single mom. Despite medical bills ...
Breaking Medicine News(10 mins):Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2Health News:'Tis the Season of Challenges for Those With Food Allergies 2Health News:Sexy Wedding Dresses with Special Discounts Launched by Angeldress.co.uk 2Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2
... and support for those suffering from anorexia. ... Lothian//, said that all measures are being taken to ... Executive said that help would be provided for people ... in the Ombudsman's report. Mr Duncanson expressed his condolences ...
... the Indian Council of Medical Research (ICMR) today signed an ... medicinal plants or multi-herb formulations that have never been compiled. ... five years was signed by ICMR Director General N K ... ,As per the MoU, the ICMR will work towards validating ...
... With dengue, viral fever and malarial attacks reported in ... to appoint 30 doctors on contract and engage para-medical ... Mayor-in-Council (Health) Subodh De said that only dengue cases ... fanned out for surveillance in the affected areas., ...
... more than 2.85 lakh population in parts of Karnataka was coming ... ,As against 1.20 lakh cases reported till April this year, it ... so far, Minister for Health R Ashok said while making a ... government has failed to take urgent steps to contain the spread ...
... conducted on 28,000 postmenopausal women has shown that those who ... were benefited by a 3 percent reduction in risk of ... completely. ,Though the scientists were not able to place ... the diabetes risk, yet they strongly feel that the presence ...
... in the United States and the Far East who use ... blindness. ,Investigators have warned contact lens users about ... lead to the withdrawal of one type of a lens ... affected. ,Researchers have also explained that many people ...
Cached Medicine News:Health News:Investigations Reveal That Infections Due To Contact lens Could Cause Blindness 2
... offers a comprehensive array of features and ... and neonate patients, to magnetic resonance imaging ... the first MR monitor designed to meet ... patient monitoring. The new monitor is also ...
... InstaTest AFP is an immunochromatographic in vitro ... (AFP) in human serum. AFP is a ... to 74,000 D. Its normal concentration in ... are associated with hepatoma and ovarian, testicular ...
... simple and flexible solution. The Coag-A-Mate ... design, but offers full automation and ... high-volume systems. It is an easy ... also be used as a back-up ...
... is a fully automated open random ... and immunological, latex based coagulation tests. ... 5-position racks as sample carrier offers ... up to 70 reagents on-board with ...
Medicine Products: